UBS’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-25,662	Closed	-$250K	–	6523
2014 Q1	$250K	Buy	25,662 +23,945	+1,395%	+$233K	﹤0.01%	3601
2013 Q4	$11K	Buy	+1,717	New	+$11K	﹤0.01%	5615